Elevance Health Faces Securities Fraud Lawsuit Over Medicaid Cost Misrepresentations

Reuters
03 Jun
<a href="https://laohu8.com/S/ELV">Elevance Health</a> Faces Securities Fraud Lawsuit Over Medicaid Cost Misrepresentations

A securities class action lawsuit has been filed against Elevance Health Inc. on behalf of investors who purchased its securities between April 18, 2024, and October 16, 2024. The lawsuit, initiated by Berger Montague PC, alleges that Elevance misrepresented its monitoring of cost trends associated with Medicaid eligibility redeterminations. Contrary to the company's assurances, the redetermination process led to a significant rise in the utilization of Medicaid members, as healthier individuals were removed from the programs. This shift was not accurately reflected in Elevance's rate negotiations or financial guidance for 2024. Investors have until July 11, 2025, to seek appointment as a lead plaintiff in the case. Elevance, based in Indianapolis, Indiana, provides health insurance plans, including Medicaid benefits.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevance Health Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 254228) on June 02, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10